Effects of neuroimmune axis modulation by aprepitant on antipruritic and global disease severity in patients with cutaneous T-cell lymphoma

Br J Dermatol. 2018 May;178(5):1221-1222. doi: 10.1111/bjd.16363. Epub 2018 Mar 2.

Authors

S G Kwatra¹, E Boozalis¹, M M Kwatra²

Affiliations

¹ Department of Dermatology, Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, MD, 21231, U.S.A.
² Department of Anesthesiology, Duke University Medical Center, Durham, NC, U.S.A.

PMID: 29352478
DOI: 10.1111/bjd.16363

No abstract available

Publication types

Letter
Comment

MeSH terms

Antipruritics
Aprepitant
Humans
Lymphoma, T-Cell, Cutaneous*
Pruritus
Skin Neoplasms*

Substances

Antipruritics
Aprepitant